APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Live Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Swine Live Vaccine Market Analysis and Forecast 2026-2032

1 January 2026190 pages

Choose your research edition.

Industry ResearchSwine Live Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Live Vaccine Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Swine Live Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Live Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Live Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Swine Live Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Swine Live Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Swine Live Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Swine Live Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Swine Live Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Swine Live Vaccine include Boehringer Ingelheim, Ceva Corporate, KM Biologics, Nisseiken, DHN, Harbin Pharmaceutical Group Bio-vaccine, Jinyu Biotechnology, Qindao Lijian Bio-Tech and Shenzhen BIOCBD Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Swine Live Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Swine Live Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Swine Live Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Swine Live Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Swine Live Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Swine Live Vaccine sales, projected growth trends, production technology, application and end-user industry.

Swine Live Vaccine Segment by Company

Boehringer Ingelheim

Ceva Corporate

KM Biologics

Nisseiken

DHN

Harbin Pharmaceutical Group Bio-vaccine

Jinyu Biotechnology

Qindao Lijian Bio-Tech

Shenzhen BIOCBD Biotechnology

Wuhan Keqian Biology

Zhongmu Industry

Swine Live Vaccine Segment by Type

Swine Fever Vaccine

Porcine Reproductive and Respiratory Syndrome Vaccine

Pseudorabies Vaccine

Others

Swine Live Vaccine Segment by Application

Breeding Farm

Veterinary Clinic

Swine Live Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Live Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Live Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Live Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Swine Live Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Swine Live Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Live Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Swine Live Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Swine Fever Vaccine Major Manufacturers Table 3. Porcine Reproductive and Respiratory Syndrome Vaccine Major Manufacturers Table 4. Pseudorabies Vaccine Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Swine Live Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Breeding Farm Major Manufacturers Table 8. Veterinary Clinic Major Manufacturers Table 9. Swine Live Vaccine Industry Trends Table 10. Swine Live Vaccine Industry Drivers Table 11. Swine Live Vaccine Industry Opportunities and Challenges Table 12. Swine Live Vaccine Industry Restraints Table 13. Global Swine Live Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Swine Live Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Swine Live Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Swine Live Vaccine Revenue Market Share by Region (2021-2026) Table 17. Global Swine Live Vaccine Revenue Market Share by Region (2027-2032) Table 18. Global Swine Live Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Swine Live Vaccine Sales by Region (2021-2026) & (K Units) Table 20. Global Swine Live Vaccine Sales by Region (2027-2032) & (K Units) Table 21. Global Swine Live Vaccine Sales Market Share by Region (2021-2026) Table 22. Global Swine Live Vaccine Sales Market Share by Region (2027-2032) Table 23. Global Swine Live Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Swine Live Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Swine Live Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Swine Live Vaccine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Swine Live Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Swine Live Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Swine Live Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Swine Live Vaccine Manufacturers, Product Type & Application Table 31. Global Swine Live Vaccine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Swine Live Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Swine Live Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Swine Live Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Swine Live Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Swine Live Vaccine Revenue Market Share by Type (2021-2026) Table 38. Global Swine Live Vaccine Revenue Market Share by Type (2027-2032) Table 39. Global Swine Live Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Swine Live Vaccine Sales by Type (2021-2026) & (K Units) Table 41. Global Swine Live Vaccine Sales by Type (2027-2032) & (K Units) Table 42. Global Swine Live Vaccine Sales Market Share by Type (2021-2026) Table 43. Global Swine Live Vaccine Sales Market Share by Type (2027-2032) Table 44. Global Swine Live Vaccine Price by Type (2021-2026) & (US$/Unit) Table 45. Global Swine Live Vaccine Price by Type (2027-2032) & (US$/Unit) Table 46. Global Swine Live Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Swine Live Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Swine Live Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Swine Live Vaccine Revenue Market Share by Application (2021-2026) Table 50. Global Swine Live Vaccine Revenue Market Share by Application (2027-2032) Table 51. Global Swine Live Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Swine Live Vaccine Sales by Application (2021-2026) & (K Units) Table 53. Global Swine Live Vaccine Sales by Application (2027-2032) & (K Units) Table 54. Global Swine Live Vaccine Sales Market Share by Application (2021-2026) Table 55. Global Swine Live Vaccine Sales Market Share by Application (2027-2032) Table 56. Global Swine Live Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Swine Live Vaccine Price by Application (2027-2032) & (US$/Unit) Table 58. Boehringer Ingelheim Company Information Table 59. Boehringer Ingelheim Business Overview Table 60. Boehringer Ingelheim Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Boehringer Ingelheim Swine Live Vaccine Product Portfolio Table 62. Boehringer Ingelheim Recent Development Table 63. Ceva Corporate Company Information Table 64. Ceva Corporate Business Overview Table 65. Ceva Corporate Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Ceva Corporate Swine Live Vaccine Product Portfolio Table 67. Ceva Corporate Recent Development Table 68. KM Biologics Company Information Table 69. KM Biologics Business Overview Table 70. KM Biologics Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. KM Biologics Swine Live Vaccine Product Portfolio Table 72. KM Biologics Recent Development Table 73. Nisseiken Company Information Table 74. Nisseiken Business Overview Table 75. Nisseiken Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Nisseiken Swine Live Vaccine Product Portfolio Table 77. Nisseiken Recent Development Table 78. DHN Company Information Table 79. DHN Business Overview Table 80. DHN Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. DHN Swine Live Vaccine Product Portfolio Table 82. DHN Recent Development Table 83. Harbin Pharmaceutical Group Bio-vaccine Company Information Table 84. Harbin Pharmaceutical Group Bio-vaccine Business Overview Table 85. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Portfolio Table 87. Harbin Pharmaceutical Group Bio-vaccine Recent Development Table 88. Jinyu Biotechnology Company Information Table 89. Jinyu Biotechnology Business Overview Table 90. Jinyu Biotechnology Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Jinyu Biotechnology Swine Live Vaccine Product Portfolio Table 92. Jinyu Biotechnology Recent Development Table 93. Qindao Lijian Bio-Tech Company Information Table 94. Qindao Lijian Bio-Tech Business Overview Table 95. Qindao Lijian Bio-Tech Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Qindao Lijian Bio-Tech Swine Live Vaccine Product Portfolio Table 97. Qindao Lijian Bio-Tech Recent Development Table 98. Shenzhen BIOCBD Biotechnology Company Information Table 99. Shenzhen BIOCBD Biotechnology Business Overview Table 100. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Portfolio Table 102. Shenzhen BIOCBD Biotechnology Recent Development Table 103. Wuhan Keqian Biology Company Information Table 104. Wuhan Keqian Biology Business Overview Table 105. Wuhan Keqian Biology Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Wuhan Keqian Biology Swine Live Vaccine Product Portfolio Table 107. Wuhan Keqian Biology Recent Development Table 108. Zhongmu Industry Company Information Table 109. Zhongmu Industry Business Overview Table 110. Zhongmu Industry Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Zhongmu Industry Swine Live Vaccine Product Portfolio Table 112. Zhongmu Industry Recent Development Table 113. North America Swine Live Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Swine Live Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Swine Live Vaccine Sales by Type (2021-2026) & (K Units) Table 116. North America Swine Live Vaccine Sales by Type (2027-2032) & (K Units) Table 117. North America Swine Live Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 118. North America Swine Live Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 119. North America Swine Live Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Swine Live Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Swine Live Vaccine Sales by Application (2021-2026) & (K Units) Table 122. North America Swine Live Vaccine Sales by Application (2027-2032) & (K Units) Table 123. North America Swine Live Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 124. North America Swine Live Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 125. North America Swine Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Swine Live Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Swine Live Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Swine Live Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 129. North America Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 130. North America Swine Live Vaccine Sales by Country (2027-2032) & (K Units) Table 131. North America Swine Live Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 132. North America Swine Live Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 133. United States Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 134. Canada Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 135. Europe Swine Live Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Swine Live Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Swine Live Vaccine Sales by Type (2021-2026) & (K Units) Table 138. Europe Swine Live Vaccine Sales by Type (2027-2032) & (K Units) Table 139. Europe Swine Live Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 140. Europe Swine Live Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 141. Europe Swine Live Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Swine Live Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Swine Live Vaccine Sales by Application (2021-2026) & (K Units) Table 144. Europe Swine Live Vaccine Sales by Application (2027-2032) & (K Units) Table 145. Europe Swine Live Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 146. Europe Swine Live Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Europe Swine Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Swine Live Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Swine Live Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Swine Live Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. Europe Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 152. Europe Swine Live Vaccine Sales by Country (2027-2032) & (K Units) Table 153. Europe Swine Live Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 154. Europe Swine Live Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 155. Germany Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 156. France Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 157. U.K. Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 158. Italy Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 159. Netherlands Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 160. China Swine Live Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 161. China Swine Live Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 162. China Swine Live Vaccine Sales by Type (2021-2026) & (K Units) Table 163. China Swine Live Vaccine Sales by Type (2027-2032) & (K Units) Table 164. China Swine Live Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 165. China Swine Live Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 166. China Swine Live Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 167. China Swine Live Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 168. China Swine Live Vaccine Sales by Application (2021-2026) & (K Units) Table 169. China Swine Live Vaccine Sales by Application (2027-2032) & (K Units) Table 170. China Swine Live Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 171. China Swine Live Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 172. Asia Swine Live Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 173. Asia Swine Live Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 174. Asia Swine Live Vaccine Sales by Type (2021-2026) & (K Units) Table 175. Asia Swine Live Vaccine Sales by Type (2027-2032) & (K Units) Table 176. Asia Swine Live Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 177. Asia Swine Live Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 178. Asia Swine Live Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Swine Live Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Swine Live Vaccine Sales by Application (2021-2026) & (K Units) Table 181. Asia Swine Live Vaccine Sales by Application (2027-2032) & (K Units) Table 182. Asia Swine Live Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 183. Asia Swine Live Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 184. Asia Swine Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Asia Swine Live Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Asia Swine Live Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Asia Swine Live Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. Asia Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 189. Asia Swine Live Vaccine Sales by Country (2027-2032) & (K Units) Table 190. Asia Swine Live Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 191. Asia Swine Live Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Japan Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 193. South Korea Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 194. India Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 195. Australia Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 196. China Taiwan Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 197. Southeast Asia Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 198. SAMEA Swine Live Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 199. SAMEA Swine Live Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 200. SAMEA Swine Live Vaccine Sales by Type (2021-2026) & (K Units) Table 201. SAMEA Swine Live Vaccine Sales by Type (2027-2032) & (K Units) Table 202. SAMEA Swine Live Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 203. SAMEA Swine Live Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 204. SAMEA Swine Live Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 205. SAMEA Swine Live Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 206. SAMEA Swine Live Vaccine Sales by Application (2021-2026) & (K Units) Table 207. SAMEA Swine Live Vaccine Sales by Application (2027-2032) & (K Units) Table 208. SAMEA Swine Live Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 209. SAMEA Swine Live Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 210. SAMEA Swine Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. SAMEA Swine Live Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. SAMEA Swine Live Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. SAMEA Swine Live Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 214. SAMEA Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 215. SAMEA Swine Live Vaccine Sales by Country (2027-2032) & (K Units) Table 216. SAMEA Swine Live Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 217. SAMEA Swine Live Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 218. Brazil Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 219. Argentina Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Chile Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Colombia Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Peru Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 223. Saudi Arabia Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 224. Israel Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 225. UAE Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 226. Turkey Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 227. Iran Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 228. Egypt Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Table 229. Key Raw Materials Table 230. Raw Materials Key Suppliers Table 231. Swine Live Vaccine Distributors List Table 232. Swine Live Vaccine Customers List Table 233. Research Programs/Design for This Report Table 234. Authors List of This Report Table 235. Secondary Sources Table 236. Primary Sources List of Figures Figure 1. Swine Live Vaccine Image Figure 2. Global Swine Live Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Live Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Swine Fever Vaccine Image Figure 5. Porcine Reproductive and Respiratory Syndrome Vaccine Image Figure 6. Pseudorabies Vaccine Image Figure 7. Others Image Figure 8. Global Swine Live Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Swine Live Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 10. Breeding Farm Image Figure 11. Veterinary Clinic Image Figure 12. Global Swine Live Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Figure 14. Global Swine Live Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Swine Live Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Swine Live Vaccine Revenue Market Share by Region (2021-2032) Figure 17. Global Swine Live Vaccine Sales (2021-2032) & (K Units) Figure 18. Global Swine Live Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Swine Live Vaccine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Swine Live Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Europe Swine Live Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. China Swine Live Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Swine Live Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Swine Live Vaccine Sales YoY (2021-2032) & (K Units) Figure 25. Global Swine Live Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Swine Live Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Swine Live Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Swine Live Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Swine Live Vaccine Revenue Market Share by Type (2021-2032) Figure 31. Global Swine Live Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Swine Live Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Swine Live Vaccine Sales Market Share by Type (2021-2032) Figure 34. Global Swine Live Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Swine Live Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Swine Live Vaccine Revenue Market Share by Application (2021-2032) Figure 37. Global Swine Live Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Swine Live Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Swine Live Vaccine Sales Market Share by Application (2021-2032) Figure 40. North America Swine Live Vaccine Revenue Share by Type (2021-2032) Figure 41. North America Swine Live Vaccine Sales Share by Type (2021-2032) Figure 42. North America Swine Live Vaccine Revenue Share by Application (2021-2032) Figure 43. North America Swine Live Vaccine Sales Share by Application (2021-2032) Figure 44. North America Swine Live Vaccine Revenue Share by Country (2021-2032) Figure 45. North America Swine Live Vaccine Sales Share by Country (2021-2032) Figure 46. Europe Swine Live Vaccine Revenue Share by Type (2021-2032) Figure 47. Europe Swine Live Vaccine Sales Share by Type (2021-2032) Figure 48. Europe Swine Live Vaccine Revenue Share by Application (2021-2032) Figure 49. Europe Swine Live Vaccine Sales Share by Application (2021-2032) Figure 50. Europe Swine Live Vaccine Revenue Share by Country (2021-2032) Figure 51. Europe Swine Live Vaccine Sales Share by Country (2021-2032) Figure 52. China Swine Live Vaccine Revenue Share by Type (2021-2032) Figure 53. China Swine Live Vaccine Sales Share by Type (2021-2032) Figure 54. China Swine Live Vaccine Revenue Share by Application (2021-2032) Figure 55. China Swine Live Vaccine Sales Share by Application (2021-2032) Figure 56. Asia Swine Live Vaccine Revenue Share by Type (2021-2032) Figure 57. Asia Swine Live Vaccine Sales Share by Type (2021-2032) Figure 58. Asia Swine Live Vaccine Revenue Share by Application (2021-2032) Figure 59. Asia Swine Live Vaccine Sales Share by Application (2021-2032) Figure 60. Asia Swine Live Vaccine Revenue Share by Country (2021-2032) Figure 61. Asia Swine Live Vaccine Sales Share by Country (2021-2032) Figure 62. SAMEA Swine Live Vaccine Revenue Share by Type (2021-2032) Figure 63. SAMEA Swine Live Vaccine Sales Share by Type (2021-2032) Figure 64. SAMEA Swine Live Vaccine Revenue Share by Application (2021-2032) Figure 65. SAMEA Swine Live Vaccine Sales Share by Application (2021-2032) Figure 66. SAMEA Swine Live Vaccine Revenue Share by Country (2021-2032) Figure 67. SAMEA Swine Live Vaccine Sales Share by Country (2021-2032) Figure 68. Swine Live Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Swine Live Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Swine Fever Vaccine
  • Porcine Reproductive and Respiratory Syndrome Vaccine
  • Pseudorabies Vaccine
  • Others
Applications
  • Breeding Farm
  • Veterinary Clinic
Companies covered
  • Boehringer Ingelheim
  • Ceva Corporate
  • KM Biologics
  • Nisseiken
  • DHN
  • Harbin Pharmaceutical Group Bio-vaccine
  • Jinyu Biotechnology
  • Qindao Lijian Bio-Tech
  • Shenzhen BIOCBD Biotechnology
  • Wuhan Keqian Biology
  • Zhongmu Industry

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Swine Live Vaccine Market by Type
  3. 1.2.1 Global Swine Live Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Swine Fever Vaccine
  5. 1.2.3 Porcine Reproductive and Respiratory Syndrome Vaccine
  6. 1.2.4 Pseudorabies Vaccine
  7. 1.2.5 Others
  8. 1.3 Swine Live Vaccine Market by Application
  9. 1.3.1 Global Swine Live Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Breeding Farm
  11. 1.3.3 Veterinary Clinic
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Swine Live Vaccine Market Dynamics
  1. 2.1 Swine Live Vaccine Industry Trends
  2. 2.2 Swine Live Vaccine Industry Drivers
  3. 2.3 Swine Live Vaccine Industry Opportunities and Challenges
  4. 2.4 Swine Live Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Swine Live Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Swine Live Vaccine Revenue by Region
  3. 3.2.1 Global Swine Live Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Swine Live Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Swine Live Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Swine Live Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Swine Live Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Swine Live Vaccine Sales by Region
  9. 3.4.1 Global Swine Live Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Swine Live Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Swine Live Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Swine Live Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Swine Live Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Swine Live Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Swine Live Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Swine Live Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Swine Live Vaccine Sales by Manufacturers
  6. 4.2.1 Global Swine Live Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Swine Live Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Swine Live Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Swine Live Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Swine Live Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Swine Live Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Swine Live Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Swine Live Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Swine Live Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Swine Live Vaccine Tier 1, Tier 2, and Tier 3
5 Swine Live Vaccine Market by Type
  1. 5.1 Global Swine Live Vaccine Revenue by Type
  2. 5.1.1 Global Swine Live Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Swine Live Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Swine Live Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Swine Live Vaccine Sales by Type
  6. 5.2.1 Global Swine Live Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Swine Live Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Swine Live Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Swine Live Vaccine Price by Type
6 Swine Live Vaccine Market by Application
  1. 6.1 Global Swine Live Vaccine Revenue by Application
  2. 6.1.1 Global Swine Live Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Swine Live Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Swine Live Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Swine Live Vaccine Sales by Application
  6. 6.2.1 Global Swine Live Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Swine Live Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Swine Live Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Swine Live Vaccine Price by Application
7 Company Profiles
  1. 7.1 Boehringer Ingelheim
  2. 7.1.1 Boehringer Ingelheim Company Information
  3. 7.1.2 Boehringer Ingelheim Business Overview
  4. 7.1.3 Boehringer Ingelheim Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Boehringer Ingelheim Swine Live Vaccine Product Portfolio
  6. 7.1.5 Boehringer Ingelheim Recent Developments
  7. 7.2 Ceva Corporate
  8. 7.2.1 Ceva Corporate Company Information
  9. 7.2.2 Ceva Corporate Business Overview
  10. 7.2.3 Ceva Corporate Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Ceva Corporate Swine Live Vaccine Product Portfolio
  12. 7.2.5 Ceva Corporate Recent Developments
  13. 7.3 KM Biologics
  14. 7.3.1 KM Biologics Company Information
  15. 7.3.2 KM Biologics Business Overview
  16. 7.3.3 KM Biologics Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 KM Biologics Swine Live Vaccine Product Portfolio
  18. 7.3.5 KM Biologics Recent Developments
  19. 7.4 Nisseiken
  20. 7.4.1 Nisseiken Company Information
  21. 7.4.2 Nisseiken Business Overview
  22. 7.4.3 Nisseiken Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Nisseiken Swine Live Vaccine Product Portfolio
  24. 7.4.5 Nisseiken Recent Developments
  25. 7.5 DHN
  26. 7.5.1 DHN Company Information
  27. 7.5.2 DHN Business Overview
  28. 7.5.3 DHN Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 DHN Swine Live Vaccine Product Portfolio
  30. 7.5.5 DHN Recent Developments
  31. 7.6 Harbin Pharmaceutical Group Bio-vaccine
  32. 7.6.1 Harbin Pharmaceutical Group Bio-vaccine Company Information
  33. 7.6.2 Harbin Pharmaceutical Group Bio-vaccine Business Overview
  34. 7.6.3 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Portfolio
  36. 7.6.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments
  37. 7.7 Jinyu Biotechnology
  38. 7.7.1 Jinyu Biotechnology Company Information
  39. 7.7.2 Jinyu Biotechnology Business Overview
  40. 7.7.3 Jinyu Biotechnology Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Jinyu Biotechnology Swine Live Vaccine Product Portfolio
  42. 7.7.5 Jinyu Biotechnology Recent Developments
  43. 7.8 Qindao Lijian Bio-Tech
  44. 7.8.1 Qindao Lijian Bio-Tech Company Information
  45. 7.8.2 Qindao Lijian Bio-Tech Business Overview
  46. 7.8.3 Qindao Lijian Bio-Tech Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Qindao Lijian Bio-Tech Swine Live Vaccine Product Portfolio
  48. 7.8.5 Qindao Lijian Bio-Tech Recent Developments
  49. 7.9 Shenzhen BIOCBD Biotechnology
  50. 7.9.1 Shenzhen BIOCBD Biotechnology Company Information
  51. 7.9.2 Shenzhen BIOCBD Biotechnology Business Overview
  52. 7.9.3 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Portfolio
  54. 7.9.5 Shenzhen BIOCBD Biotechnology Recent Developments
  55. 7.10 Wuhan Keqian Biology
  56. 7.10.1 Wuhan Keqian Biology Company Information
  57. 7.10.2 Wuhan Keqian Biology Business Overview
  58. 7.10.3 Wuhan Keqian Biology Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Wuhan Keqian Biology Swine Live Vaccine Product Portfolio
  60. 7.10.5 Wuhan Keqian Biology Recent Developments
  61. 7.11 Zhongmu Industry
  62. 7.11.1 Zhongmu Industry Company Information
  63. 7.11.2 Zhongmu Industry Business Overview
  64. 7.11.3 Zhongmu Industry Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Zhongmu Industry Swine Live Vaccine Product Portfolio
  66. 7.11.5 Zhongmu Industry Recent Developments
8 North America
  1. 8.1 North America Swine Live Vaccine Market Size by Type
  2. 8.1.1 North America Swine Live Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Swine Live Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Swine Live Vaccine Price by Type (2021-2032)
  5. 8.2 North America Swine Live Vaccine Market Size by Application
  6. 8.2.1 North America Swine Live Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Swine Live Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Swine Live Vaccine Price by Application (2021-2032)
  9. 8.3 North America Swine Live Vaccine Market Size by Country
  10. 8.3.1 North America Swine Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Swine Live Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Swine Live Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Swine Live Vaccine Market Size by Type
  2. 9.1.1 Europe Swine Live Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Swine Live Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Swine Live Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Swine Live Vaccine Market Size by Application
  6. 9.2.1 Europe Swine Live Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Swine Live Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Swine Live Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Swine Live Vaccine Market Size by Country
  10. 9.3.1 Europe Swine Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Swine Live Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Swine Live Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Swine Live Vaccine Market Size by Type
  2. 10.1.1 China Swine Live Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Swine Live Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Swine Live Vaccine Price by Type (2021-2032)
  5. 10.2 China Swine Live Vaccine Market Size by Application
  6. 10.2.1 China Swine Live Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Swine Live Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Swine Live Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Swine Live Vaccine Market Size by Type
  2. 11.1.1 Asia Swine Live Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Swine Live Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Swine Live Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Swine Live Vaccine Market Size by Application
  6. 11.2.1 Asia Swine Live Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Swine Live Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Swine Live Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Swine Live Vaccine Market Size by Country
  10. 11.3.1 Asia Swine Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Swine Live Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Swine Live Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Swine Live Vaccine Market Size by Type
  2. 12.1.1 SAMEA Swine Live Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Swine Live Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Swine Live Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Swine Live Vaccine Market Size by Application
  6. 12.2.1 SAMEA Swine Live Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Swine Live Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Swine Live Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Swine Live Vaccine Market Size by Country
  10. 12.3.1 SAMEA Swine Live Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Swine Live Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Swine Live Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Swine Live Vaccine Value Chain Analysis
  2. 13.1.1 Swine Live Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Swine Live Vaccine Production Mode & Process
  6. 13.2 Swine Live Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Swine Live Vaccine Distributors
  9. 13.2.3 Swine Live Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst